David E. Wheadon
CIK 1789507 · last filed 2026-07-17
David E. Wheadon is a corporate insider who has filed 26 SEC Form 4 insider transactions across 7 companies since 2019. Across all open-market trades the lifetime net is +$62.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.89M
7
26
$62.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SHC | Director | 89,882 | $18.97 | $1.71M | $0 | 6 | 2026-05-27 |
| INDV | Director | 30,780 | $38.47 | $1.18M | $62.7K | 3 | 2026-05-14 |
| SPTX | Director | — | $23.02 | — | $0 | 1 | 2026-05-04 |
| Vaxart, Inc. (VXRT) Delisted | Director | 46,750 | $0.32 | $15.0K | $0 | 5 | 2025-06-16 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $0 | 5 | 2024-03-18 |
| CCXI | Director | — | $16.10 | — | $0 | 2 | 2022-10-24 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director | 4,764 | $23.50 | $112.0K | $0 | 3 | 2020-09-29 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | — | Grant (A) | +39,400 | $0 | |
| 2026-05-27 | SHC | Grant (A) | +14,970 | $0 | EDGAR |
| 2026-05-14 | INDV | Grant (A) | +10,430 | $0 | EDGAR |
| 2026-05-04 | SPTX | Grant (A) | — | $0 | EDGAR |
| 2026-01-28 | INDV | Grant (A) | +5,955 | $0 | EDGAR |
| 2026-01-07 | INDV | Buy (P) | +1,771 | $62.7K | EDGAR |
| 2025-06-16 | Vaxart, Inc. (VXRT) Delisted | Grant (A) | +16,000 | $0 | EDGAR |
| 2025-05-27 | SHC | Grant (A) | +19,132 | $0 | EDGAR |
| 2024-06-12 | Vaxart, Inc. (VXRT) Delisted | Grant (A) | +16,000 | $0 | EDGAR |
| 2024-05-29 | SHC | Grant (A) | +20,089 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.